Trial · NCT02788006
Adverse events46
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 46
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Aspartate aminotransferase increased | Investigations | Regorafenib 160 mg | 21 | 42 | |
| other | Alanine aminotransferase increased | Investigations | Regorafenib 160 mg | 12 | 42 | |
| other | Total Bilirubin increased | Investigations | Regorafenib 160 mg | 22 | 42 | |
| other | Gamma-glutamyltransferase increased | Investigations | Regorafenib 160 mg | 31 | 42 | |
| other | White blood cell count decreased | Investigations | Regorafenib 160 mg | 4 | 42 | |
| other | Lipase increased | Investigations | Regorafenib 160 mg | 7 | 42 | |
| other | Neutrophils decreased | Investigations | Regorafenib 160 mg | 4 | 42 | |
| other | Lymphocytes decreased | Investigations | Regorafenib 160 mg | 3 | 42 | |
| other | Phosphatases Alcalines increased | Investigations | Regorafenib 160 mg | 21 | 42 | |
| other | Platelets decreased | Investigations | Regorafenib 160 mg | 20 | 42 | |
| other | Hypertension | Cardiac disorders | Regorafenib 160 mg | 12 | 42 | |
| other | Anemia | Blood and lymphatic system disorders | Regorafenib 160 mg | 19 | 42 | |
| other | Dysphonia | Respiratory, thoracic and mediastinal disorders | Regorafenib 160 mg | 11 | 42 | |
| other | Headache | Nervous system disorders | Regorafenib 160 mg | 3 | 42 | |
| other | Dysgueusia | Nervous system disorders | Regorafenib 160 mg | 4 | 42 | |
| other | Fatigue | General disorders | Regorafenib 160 mg | 34 | 42 | |
| other | Pyrexia | General disorders | Regorafenib 160 mg | 7 | 42 | |
| other | Constipation | Gastrointestinal disorders | Regorafenib 160 mg | 13 | 42 | |
| other | Diarrhoea subjects | Gastrointestinal disorders | Regorafenib 160 mg | 17 | 42 | |
| other | Abdominal pain | Gastrointestinal disorders | Regorafenib 160 mg | 9 | 42 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02788006/events